Pacific Biosciences of California Inc (NAS:PACB)
$ 1.86 -0.07 (-3.63%) Market Cap: 568.03 Mil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 1.17 GF Score: 55/100

Pacific Biosciences of California Inc at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 03:00PM GMT
Release Date Price: $14.05 (+1.22%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Thanks for joining us this morning. My name is Matt Sykes. I'm the life science tools and diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming CEO of PacBio, Christian Henry, here to our conference this morning. Christian, thanks for coming.

Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director

Yes. Thank you. My commute was short today.

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Yes. We try to make it easy for you.

Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director

Thank you.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe I think it would be helpful for you to maybe set the stage for us, just talk about sort of the key

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot